Abstract:ObjectivesThe aim of this study was to shorten the 4-h delay between the intravenous administration of gadolinium and MRI acquisition for hydrops evaluation using an optimized 3D-FLAIR sequence in patients with Menière’s disease.MethodsThis was a single-center prospective study including 29 patients (58 ears), recruited between November 2020 and February 2021. All patients underwent a 3-T MRI with an optimized 3D-FLAIR sequence without contrast then at 1 h, 2 h, and 4 h after intravenous administration of gadobutrol. The signal intensity ratio was quantitatively assessed with the region of interest method. We also evaluated the volume of endolymphatic structures (saccule, utricle) then the presence of endolymphatic hydrops and blood-labyrinthine barrier impairment at each acquisition time.ResultsFor all ears, the signal intensity ratio was significantly non-inferior at 2 h compared to 4 h, with a mean geometric signal intensity ratio at 0.83 (95% CI: 0.76 to 0.90, one-sided p < .001 for non-inferiority at −30% margin). Mean volume equivalence of saccule and utricle between 2 and 4 h was proven at a ± 0.20 standardized deviation equivalence margin. Intra-rater agreements (Cohen’s kappa) were all greater than 0.90 for all endolymphatic hydrops location and blood-labyrinthine-barrier impairment between the 2- and 4-h assessments.ConclusionsWe demonstrated that using an optimized 3D-FLAIR sequence we could shorten the acquisition from 4 to 2 h with a high reliability for the diagnosis of endolymphatic hydrops and blood-labyrinthine-barrier impairment.Clinical trial registrationClinical trial no: 38RC15.173Key Points• Magnetic resonance imaging with delayed 3D-FLAIR sequences allows the diagnosis of endolymphatic hydrops in patients with definite Menière’s disease.• An optimized 3D-FLAIR sequence with a long TR of 16000 ms and a constant flip angle allows for reducing the delay between intravenous injection of gadobutrol and MRI acquisition from 4 to 2 h to diagnose endolymphatic hydrops.• Reducing this delay between intravenous injection and MRI acquisition could have implications for clinical practice for both patients and imaging departments.

The impact of 3D real-IR delayed post gadolinium MRI parameterisation on the diagnostic performance and optimal descriptor selection in Ménière's disease

Assessing the optimal MRI descriptors to diagnose Ménière's disease and the added value of analysing the vestibular aqueduct

Correlation of endolymphatic hydrops and perilymphatic enhancement with the clinical features of Ménière's disease

Comparison of an Optimized 3D-Real IR and a 3D-FLAIR with a Constant Flip Angle in the Evaluation of Endolymphatic Hydrops

Inner Ear MRI Enhancement Based on Three Dimensional‐real IR Sequence in Patients with Meniere’s Disease after Intravenous Gadolinium Injection: Comparison of Different Doses Used and Exploration of an Appropriate Dose

A three-dimensional inversion-recovery with real reconstruction sequence with an ultralong repetition time for endolymphatic hydrops of Meniere disease after intravenous enhancement: a preliminary application

3D-real IR MRI of Meniere's disease with partial endolymphatic hydrops.

The Value of 3D-Real IR MRI with Intravenous Gadolinium Injection in the Diagnosis of Suspected Meniere’s Disease in Children

Magnetic Resonance Imaging with Intravenous Gadoteridol Injection Based on 3D-Real IR Sequence of the Inner Ear in Meniere’s Disease Patient: Feasibility in 3.5-H Time Interval

Delayed Contrast MRI for the Evaluation of Ménière's Disease – An Australian Perspective

The Assessment of Endolymphatic Hydrops with High-resolution 3 D Real Inversion Recovery and 3 D Fluid Attenuated Inversion Recovery Sequences

Four-Hour-Delayed Gadolinium 3D REAL IR and SPACE FLAIR MRI Correlated to Meniere Disease Histology

Comparative analysis of vestibular endolymphatic hydrops grading methods and hearing loss in Ménière's disease: a retrospective MRI study using 3D-real inversion recovery sequence

Magnetic Resonance Imaging of Ménière's Disease after Intravenous Administration of Gadolinium.

Comparison between audio-vestibular findings and contrast-enhanced MRI of inner ear in patients with unilateral Ménière's disease

Optimized 3D-FLAIR sequences to shorten the delay between intravenous administration of gadolinium and MRI acquisition in patients with Menière’s disease

Magnetic resonance imaging of intratympanic gadolinium helps differentiate vestibular migraine from Ménière disease

Differentiating Definite and Probable Ménière Disease: A Comprehensive Evaluation of Audio-Vestibular Function Testing Combined with Inner Ear MRI

The characteristics of three-dimensional real inversion recovery MRI sequence in delayed Meniere's disease

Comprehensive comparison of MR image quality between intratympanic and intravenous gadolinium injection using 3D real IR sequences.

A 3-hour time interval may not be sufficient for delayed enhancement magnetic resonance imaging with intravenous gadoteridol injection based on 3d-real IR sequence of the inner ear in Meniere's disease patient